The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(2-(dimethylamino)ethyl)-4-(4-(thiophen-3-yl)pyrimidin-2-ylamino)benzenesulfonamide ID: ALA1085880
PubChem CID: 46890320
Max Phase: Preclinical
Molecular Formula: C18H21N5O2S2
Molecular Weight: 403.53
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CN(C)CCNS(=O)(=O)c1ccc(Nc2nccc(-c3ccsc3)n2)cc1
Standard InChI: InChI=1S/C18H21N5O2S2/c1-23(2)11-10-20-27(24,25)16-5-3-15(4-6-16)21-18-19-9-7-17(22-18)14-8-12-26-13-14/h3-9,12-13,20H,10-11H2,1-2H3,(H,19,21,22)
Standard InChI Key: AUZFWDQAVYWVTD-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
1.9984 -4.1511 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.4156 -4.8688 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
2.8284 -4.1486 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.8693 -6.5319 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.1520 -6.1181 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1549 -5.2865 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.8711 -4.8768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4360 -6.5300 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.2788 -6.1158 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9915 -6.5282 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7057 -6.1147 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7049 -5.2877 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9838 -4.8760 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2726 -5.2918 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1356 -5.2836 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.2975 -6.5336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5814 -6.1240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5758 -5.2951 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.0454 -6.1923 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.5998 -6.8031 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-4.1902 -7.5192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.3827 -7.3508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8507 -4.8699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5665 -5.2823 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2815 -4.8686 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.9972 -5.2810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2807 -4.0425 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6 7 2 0
13 14 2 0
14 9 1 0
12 2 1 0
7 18 1 0
2 15 1 0
17 4 1 0
5 8 1 0
2 1 2 0
16 17 1 0
17 18 2 0
16 19 2 0
8 9 1 0
4 5 2 0
9 10 2 0
3 2 2 0
19 20 1 0
20 21 1 0
21 22 2 0
22 16 1 0
10 11 1 0
15 23 1 0
5 6 1 0
23 24 1 0
11 12 2 0
24 25 1 0
25 26 1 0
12 13 1 0
25 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 403.53Molecular Weight (Monoisotopic): 403.1137AlogP: 2.79#Rotatable Bonds: 8Polar Surface Area: 87.22Molecular Species: NEUTRALHBA: 7HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.62CX Basic pKa: 7.50CX LogP: 2.83CX LogD: 2.47Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.60Np Likeness Score: -2.30
References 1. Crombie AL, Sum FW, Powell DW, Hopper DW, Torres N, Berger DM, Zhang Y, Gavriil M, Sadler TM, Arndt K.. (2010) Synthesis and biological evaluation of tricyclic anilinopyrimidines as IKKbeta inhibitors., 20 (12): [PMID:20471256 ] [10.1016/j.bmcl.2010.04.022 ]